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The very favorable results from treatment of Type I  pneumonias 
and the encouraging although less favorable results in Type II led the 
clinicians who were aiding in  the general pneumonia investigation* 
to try serum treatment in Type III infections.  As the observations 
and statistics  of  Bullowa,  t Rosenbluth) Park,  Bullowa and Rosen- 
bluth,  ~ Cecil and Sutliff  s of the treatment of patients with Type III 
pneumonia with  specific antiserum did not indicate very favorable 
results, it seemed to us that it would be interesting to study the effect 
of the Type III antiserum in the treatment of pneumonia in experi- 
mental animals.  The progress of the disease could be compared with 
that of Type I  pneumonia in which serum treatment of patients has 
proved to be of value.  In case the animals could be infected and cured, 
the relative amount of serum necessary could be found and might fur- 
nish data on  which to base a plan of dosage for further clinical trial 
of the antiserum. 
The production of an infection by intradermal inoculation and the 
subsequent intravenous inoculation of a  single dose of antiserum was 
carried out by a technique slightly modified from that used by Good- 
*  This investigation was carried out under the direction of Dr. Park and was aided 
by grants of money from the New York University Littauer Pneumonia Fund and 
the Metropolitan Life Insurance Influenza Commission for part of the expense. 
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net*  in  his  Type  I  intradermal  pneumonia  experiments.  Goodner 
showed that by the injection of a  small  amount of Type I  pneumo- 
coccus culture intradermally  a local lesion and a bacteremia could be 
produced and that the infection was fatal for about 96 per cent of the 
rabbits inoculated.  He showed that the bacteremia and the develop- 
ment of the lesion could be checked and that recovery took place when 
suitable amounts of Type I  antiserum were given.  He suggested that 
this method be used for the  standardization  of Type I  antipneumo- 
coccus serum. 
For our  experimental  work in  treating  the  Type IIl  infections  a 
concentrated  Type III  antiserum  was used which was estimated by 
mouse protection tests to have I000 units per cubic centimeter against 
the stock Type Ill strain.  This strain was the one used for immuniza- 
tion of the horse from which the antiserum used for the therapeutic 
preparation  was obtained.  This  antiserum,  however, by the mouse 
protection test had only 1 or 2 units per cubic centimeter protection 
against  the  freshly  isolated  Type III  strain,  "Schultz,"  which  was 
used for one of the series of intradermal infection tests reported below. 
The Type IIl "Schultz" strain was recovered from the lung of a post- 
mortem  case February  17,  1930.  The  three other Type llI  strains 
used to produce infection in rabbits were "R3," the stock laboratory 
strain,  "Cartell,"  a  strain  isolated from  the meninges  December  19, 
1929, and "Challenger" isolated from the blood of a fatal case April 9, 
1930.  A comparative study of the development of the skin lesion and 
bacteremia  and  the  therapeutic  treatment  with  antisera  was made 
using the Type Ill strains and a Type I strain. 
Method 
The cultures were grown in beef heart broth (pH 7.5) to which small amounts ot 
sterile defibrillated horse blood had been added.  All cultures were of such a viru- 
lence that 0.000,000,01 cc. of an 18 hour standardized culture given intraperitoneally 
killed mice in 48 to 72 hours.  The virulence was tested by injecting the high 
dilutions of the culture into mice about ½ hour before the intradermal  injection 
was made in the rabbits. 
Healthy gray rabbits, male or female, weighing 1525 to 2750 gin. were selected. 
The abdominal area of each rabbit was shaved and depilated the day previous 
4  Jour. Exp. Med., 1928, 48, 1 and 413. 
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to the inoculation.  Inoculation was made 6 to 7 cm. lateral to the rabbit's ventral 
midline.  Each  animal  received  an  intradermal  injection  of  0.001,  0.0005  or 
0.0002 cc. of pneumococcus culture. 
Eighteen hours after inoculation, 1 cc. of blood was withdrawn from the marginal 
vein of the ear, by means of a Sterile syringe, and expelled into a  tube containing 
1 cc. of  2 per cent  citrated beef heart broth.  Previous experiments had proved 
that  2  per cent sodium citrate in rabbit blood,  the smallest  amount  that could 
be depended upon to prevent  coagulation,  did not very appreciably inhibit  the 
growth of pneumococci.  As soon as possible  0.1,  0.3  and 0.6  cc.  were pipetted 
from the citrated blood broth suspension into sterile  petri dishes  and melted agar, 
cooled to 45°C., to which 2 per cent horse blood had been added, was poured into 
the petri dishes.  The citrated rabbit blood and agar were gently rotated until the 
mixture was uniform.  The plates were incubated for 24 to 48  hours  at  37.5°C. 
The sum of the colony count of the three plates is approximately the number of 
diplococci per 0.5 cc. of blood. 
The remaining 1 cc. of citrated rabbit blood dilution was added to beef heart 
blood broth.  Occasionally pneumococci will grow in the liquid medium when the 
poured plates for a  given blood culture are negative.  Blood broth cultures were 
made from the heart's blood of animals which died during the course of an ex- 
periment, or which were killed at the conclusion of an experiment. 
Preliminary  experiments  were  carried  out  to determine  the  extent 
and  character  of  the  lesion  produced  by Type  III  strains  and  their 
power of invading the blood stream (Table I). 
A stock strain "Rs"  which has been passed through mice at least once a week 
dining its cultivation in the laboratory for many years and a freshly isolated strain, 
"Cartell," were inoculated intradermally into rabbits.  Four rabbits received the 
"R~" strain and two rabbits received the "Cartell" strain in 0.001 cc. doses.  The 
stock strain in a  dose estimated to contain  130,000 diplococci stimulated  lesions 
of different severity in individual rabbits which lasted from 2  to  10 days.  The 
freshly isolated  strain  "Cartell," in  a  dose  containing  350,000  diplococci,  pro- 
duced severe lesions lasting until death of the animals.  Later,  because of the early 
death of the rabbits in the first experiment, the "Cartell" strain, after preliminary 
passage through a rabbft, was injected into six fabblts in duplicate doses of 0.001, 
0.0005 and 0.0002 cc.  One of the animals which received 0.001 cc., 120,000 organ- 
isms,  had a  slight  lesion lasting only 3  days.  The other developed a  lesion of 
moderate severity which lasted until its death on the ninth day.  One of the rab- 
bits inoculated with one half as many diplococci, 0.0005  ce., developed a  severe 
lesion  and died on the sixth  day.  The other rabbit  had a  slight  lesion  on the 
second day and  survived.  The rabbits which received 0.0002  cc., 24,000  organ- 
isms,  developed moderate  lesions which  lasted in one instance until  the death of 
the animal on the tenth day and in the other more than 14 days. 852  TYPE III PNEITMOCOCCUS  INFECTION 
The  Type III lesion was found  to be definitely  established  at  18 
to 48 hours as a slightly swollen area 1 to 5 cm. in diameter, regardless 
of whether the strain used was a stock or freshly isolated one.  The 
redness and edema increased to 3 to 10 cm. with parts of the surface 
of the lesion hemorrhagic after 2 to 3 days.  In our experiments Type 
III strains did not produce necrosis, nor did the lesions tend to spread 
extensively over the  abdomens of the rabbits.  The  development of 
the lesion in rabbits inoculated with Type I  culture was much more 
rapid  than  in  those inoculated with Type III.  Redness and  edema 
of 5 to 10 cm. with hemorrhage was not unusual 24 hours after intra- 
dermal inoculation.  Necrosis with seepage of exudate at central  area 
of  lesion  was  pronounced  in  95  per  cent  of  the  untreated  Type  I 
rabbits in 48 to 72 hours. 
The comparative power of the different Type III strains to invade 
the blood stream was as follows: The stock strain used in four rabbits 
was not found in the blood stream over a  period of 13 days.  Three 
of the four animals survived.  One rabbit died on the seventh day but 
no  pneumococci  were  recovered  from  the  heart's  blood at  autopsy. 
On the twenty-eighth day the remaining animals were killed and autop- 
sies made.  No pneumococci were found in  cultures made from  the 
heart's blood of these animals.  The freshly isolated strain "Cartell," 
inoculated  into  two  rabbits,  caused  their  death  within  48  hours. 
Plate counts of the blood of these animals  18 hours after inoculation 
showed  186  pneumococcus colonies per cubic centimeter  in one and 
in  the other,  numbers  too great  to  count in  the  amount  examined. 
Pneumococci were recovered from the heart's blood at autopsy. 
The  results with  the rabbits inoculated with Type III,  "Cartell," 
in doses of 0.001,  0.0005  and 0.0002  cc. were as follows: one of the 
rabbits inoculated with 0.001 cc. culture, actually one-third the num- 
ber of organisms injected in the first "Cartell"  experiment, died after 
a  bacteremia  of  8  days duration.  The  other  rabbit  had  a  positive 
blood culture on the  sixth, seventh  and  eighth  day and  died on  the 
ninth day.  It is interesting that pneumococci were recovered as late 
as the fourteenth day from the blood stream of two rabbits which sur- 
vived after the inoculation with 0.0005 cc. and with 0.0002 cc. culture. 
In two instances pneumococci were found to be present in the blood in 
24 hours after injection.  In one rabbit pneumococci were found after ELIZABETH L. WATSON  AND GEORGIA COOPER  853 
48 hours, in another after 72 hours and in a third after 96 hours.  Two 
of these rabbits died.  The rabbit which survived had over 1660 or- 
ganisms  per  cubic  centimeter at  72  hours,  126  organisms  per  cubic 
centimeter at 96 hours and later four negative blood cultures with sub- 
sequent  occurrence of  small  numbers  of organisms  in  the  blood for 
5 days. 
The invasive power of a  Type I  stock strain  inoculated intrader- 
mally in a  dose of 0.001  cc. into eight rabbits is given for comparison 
(Table  II)  with  the  results  with  Type III.  Pneumococci  were  re- 
covered from  the  blood stream  of all  the  rabbits  18  hours  after the 
intradermal  injection of  the  culture.  The  dose  of diplococci intro- 
duced into the rabbits varied from 130,000 to 400,000 but there was no 
correlation between the severity of lesion or the day of death and the 
number of diplococci injected.  All animals died in 3  to 6  days after 
inoculation  of  the  culture.  Pneumococci  were  recovered  from  the 
heart's blood at autopsy. 
The effect of treatment of rabbits infected with Type III pneumo- 
cocci with Type III antiserum was investigated (Table III). 
The freshly isolated "Cartell" strain, which  was used in the experiments  re- 
ported above, and a still more recently isolated  Type III strain,  "Schultz" were 
used for these tests.  0.001  cc. of these strains was inoculated intradermally into 
two series of rabbits.  All animals responded with definite lesions and bacteremia 
in 18 hours.  Two animals of each series received no antiserum and served as con- 
trols and the other four received a single intravenous injection of Type III anti- 
serum  24 hours after the intradermal  inoculation  of  the  cultures.  Relatively 
large amounts of serum were tried because the results in mice led us to believe that 
in Type III infections large amounts would be necessary.  Those inoculated  with 
the "Schultz" strain were protected by 20 cc. of serum, 20,000 units, and the blood 
cultures remained negative after treatment.  The blood cultures  of the rabbit 
receiving l0 cc., 10,000 units,  were found to be negative after treatment and until 
after the death of the animal when pneumococci were found in the heart's  blood 
cultures at autopsy.  The rabbit receiving 5000 units died 1 day after treatment. 
No  pneumococci  however,  were  recovered from the  heart's  blood  at  autopsy. 
It is probable that this rabbit did not die because of the failure of the serum  to 
protect but from some other cause.  Of the first series of rabbits injected with the 
"Cartell" strain,  the blood  cultures of those receiving  10,000 and  20,000 units 
were found negative after treatment and the animals survived.  The blood of the 
rabbit receiving  5000 units was found positive on the first day, negative on  the 
second day, 24 hours after treatment and positive  again  on the third day; but 854  TYPE III PNE~OCOCCUS INFECTION 
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after that was found negative and the rabbit survived.  No end point of protection 
was found in this experiment. 
Another series of  rabbits injected intradermaUy with the "Cartell" strain was 
treated with smaller doses of serum.  The blood cultures of those receiving 5000 
and  1000  units  were  found  negative after  treatment  and  the  rabbits survived. 
The blood cultures of one of the rabbits receiving 500 units was positive on first, 
negative on the second day, 24 hours after treatment, positive again on the third 
and fourth day and the rabbit survived.  The other rabbit which was killed on the 
tenth  day because of a  severe diarrhoea had positive blood cultures for 8  days. 
Apparently the dose of 500 units of serum did not check the infection sufficiently 
to clear the blood at once of pneumococci but delayed its development long enough 
to aid the rabbits to recover. 
The treatment of two series of rabbits inoculated with another freshly isolated 
Type III strain, "Challenger," was carried out.  The "Challenger"  strain was iso- 
lated from the blood of a fatal case of pneumonia.  In the first series the control 
rabbits died on the fifth and sixth days.  The rabbits receiving 1000 units or more 
of Type III antiserum survived.  The rabbits receiving 300 and 500 units of serum 
died on  the second and  the sixth  day,  respectively.  It is uncertain how far the 
overwhelming bacteremia developed in these last two rabbits before treatment in- 
fluenced the determination of the end point of protection as all the other rabbits at 
that time had only a few or no organisms in the blood. 
Therefore, we tested another series of rabbits with the purpose of determining 
the end point of protection, more certainly.  Our results in this series were not 
fully satisfactory as the plates made from the blood of the rabbits to determine the 
extent  of  the  bacteremia before inoculation were  so  badly contaminated  with 
Streptococcus viridans which was present as a contamination in the horse blood used 
for the blood agar,  as to render it impossible to count the pneumococcus colonies 
accurately.  One  of  the  rabbits  receiving  150  units  of  serum  died,  the  other 
had a  bacteremia for 8 days and recovered.  With one exception, all the rabbits 
which received 300  units or more had no positive blood cultures after treatment 
and survived; one rabbit receiving 500 units either had an overwhelming bacter- 
emia before treatment or developed it shortly afterwards and died on the fourth 
day of the infection.  Protection occurred in this series of rabbits with a  smaller 
anhount of serum than we had expected. 
Results obtained with  rabbits inoculated with Type  I  pneumococci 
and  treated  with  Type  I  antiserum  or  concentrated  antiserum  are 
given for comparison (Table V). 
A series of six rabbits received by intradermal injection 0.001  cc. dose of Type I 
culture containing 200,000  diplococci.  Eighteen hours  after inoculation  all the 
rabbits were found to have positive blood cultures.  Six hours later four of the 
rabbits received a single injection of serum containing one of the following amounts: 858  TYPE  III  PNEI/&fOCOCCUS  INYECTION 
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150 units, 300 units, 600 units or 1200 units.  The rabbit receiving 150 units like 
the control rabbits died on the fourth day.  The rabbits receiving 300  and 1200 
units  survived.  The  one receiving  600  units  had  two  negative  blood  cultures 
after treatment but died on the fourth day after an injury to the heart inflicted in 
making a bleeding.  Pneumococci were recovered from the heart's blood. 
Another series of six rabbits after inoculation with a Type I culture were injected 
24 hours later with Type I  antiserum as follows:  two of the animals received 2 cc., 
300  units  of antiserum,  and  two received 4  cc.,  600  units  of antiserum.  The 
other two rabbits were held for controls.  The animals developed slight to moder- 
ate lesions  within 18 hours after the inoculation of the culture.  The blood of one 
of the rabbits  receiving  300  units  of  antiserum,  was  estimated  to contain  500 
diplococci per cubic centimeter  at  18 hours;  the bacteremia  continued  to  pro- 
gress until the sixth day, at which time the animal died.  Pneumococci were re- 
covered from  the  heart's  blood at  autopsy.  The  other  rabbit  receiving  2  cc., 
300  units  of antiserum,  developed an initial  bacterial count of 1000  diplococci, 
but there was a gradual decrease in numbers each day until the fifth day only 100 
colonies were estimated to be present in 1 cc. of blood.  The rabbit died on the 
sixth day.  Pneumococci were recovered from the heart's blood at autopsy.  The 
antiserum given in a  4 cc. dose sterilized the blood of one rabbit, while the blood 
of the other remained positive for 72 hours before becoming sterile.  Both animals 
survived the pneumococcus infection. 
Another group of five rabbits was inoculated with the Type I  stock strain and 
treated with Type I concentrated antiserum.  They received intradermal inocula- 
tion of 0.001 cc. of Type I  culture, which was estimated to contain 150,000 diplo- 
cocci per cubic centimeter and 24 hours later intravenous injection of a single dose 
of the following amounts of the concentrated antiserum: 0.1 cc., 150 units; 0.2 cc., 
300 units or 0.5 cc., 750 units.  A 0.1 cc. dose of the preparation,  150 units, was 
not sufficient to neutralize the pneumococcus infection in a rabbit which died the 
seventh day of the disease.  A culture made from the heart's blood at autopsy was 
positive.  In rabbits receiving 0.2  and 0.5 cc. doses the bacteremia was checked 
after treatment.  Both rabbits survived the infection. 
The control animals of both the Type I  series  just discussed developed maxi- 
mum lesions and a progressive bacteremia and died in 2 to 5 days. 
DISCUSSION 
The  virulence  of  freshly isolated  Type  III  strains  for rabbits  was 
apparently somewhat less than that of Type I  as shown by the slighter 
lesion and the later development of the bactererMa.  However, all the 
untreated  rabbits,  eighteen  in  number,  inoculated  with  Type  III  in 
doses of 100,000 diplococci or more,  died.  Two of the rabbits inocu- 
lated  with  smaller  doses  survived.  If  these  are  excluded,  and  only 
those  taken  into  account which  received 0.001  cc.,  the  amount given 862  TYPE  III PI~ED-MOCOCCUS  INFECTION 
to the animals which were treated, the mortality with this dose was 
100 per cent.  If the rabbits receiving the smaller amounts are in- 
cluded, twenty rabbits of twenty-two died making a mortality of 90 
per cent. 
Although the number of rabbits treated is too few to allow a  close 
comparison of  the  relative  amounts of  serum  required,  the results 
indicate that the amounts of Type III serum required to protect rab- 
bits injected intradermally with  freshly isolated Type III  cultures 
were not appreciably, if any, greater than the quantity of Type I serum 
necessary  to  protect  rabbits  inoculated  with  Type  I  culture.  As 
Type III apparently is slightly less virulent for rabbits than Type I 
and it has been found by clinical observation that Type III is more 
virulent for man than Type I, it is not possible to draw inferences 
from these experiments as to the relative amounts of serum required 
for treatment of Type I and Type III pneumonia  in man. 
In spite of this it has been encouraging to  find Type III  serum 
potent for  protecting rabbits  against infection with freshly isolated 
Type III strains because it was so little effective in protecting mice 
against  these strains.  The Type III  antiserum used in  the  above 
experiments had by the mouse protection tests only 1 to 10 units of 
protection against freshly isolated strains and  100  to  1000  times as 
much serum was  required to  protect mice  inoculated  intraperito- 
neally with these strains  as with the fully virulent (see above) stock 
strain.  Clinical  trial  has indicated that  Type I  therapeutic serum 
should have a potency somewhat higher than the early Hygienic Lab- 
oratory  standard  (100  units  per  cubic  centimeter)  and  preferably 
should have 500 units or more per cubic centimeter.  It is reasonable 
to  believe  that  Type  III  therapeutic  serum should be  of  equal  or 
greater  potency than  Type I.  If  the potency standards in mouse 
protection units for Type I  sera were applicable to Type III, then the 
Type III therapeutic sera having only 1 to  25  units protection per 
cubic centimeter against freshly isolated Type III cultures would be 
of  little  use.  However,  while  the  mouse protection  test probably 
furnishes a fairly satisfactory basis for comparing the relative potency 
of sera of the same type, it is doubtful whether it is an adequate basis 
for comparing the strength of the sera of one type with those of an- 
other for treatment of pneumonia in man or in animals other than the ELIZABETH  L.  WATSON  AND  GEORGIA  COOPER  863 
mouse.  Our experiments in treating intradermal pneumonia in rab- 
bits support this  view.  It is  probable  that  the suitable  dosage of 
hom~)logous serum for pneumonias caused by each type will have to 
be determined by clinical trial  of serum standardized arbitrarily in 
mouse protection units as to its relative potency. 
Unless it is shown that the determination of the strength of sera 
by titration of their protective effect in the intradermal pneumonia 
of rabbits gives more accurate or additional information as to their 
therapeutic value, we believe the method to be impractical as a routine 
method for  standardization  because it is more laborious and more 
expensive than the mouse method. 
SUMMARY 
Intradermai lesions and  subsequent bacteremia were produced in 
rabbits  by  the intradermai  inoculation of Type III  strains  freshly 
isolated from pneumonia cases.  Slight intradermal lesions were pro- 
duced but no bacteremia was found in rabbits inoculated with an old 
stock Type III strain. 
The intradermai lesions and the bacteremia produced by the inocu- 
lation of Type III  cultures in  rabbits were usually less severe than 
those produced by the inoculation of Type I culture. 
The bacteremia in rabbits was checked and the rabbits protected 
by suitable amounts of Type III concentrated antiserum given intra- 
venously 24 hours after the infecting dose. 
The  amount of  Type  III  antiserum necessary to protect rabbits 
inoculated intradermally with  virulent  Type  III  cultures  was  not 
appreciably greater than the amount of Type I  antiserum required to 
protect against Type I. 